Harvard Bioscience
HBIO
81 hedge funds and large institutions have $65.1M invested in Harvard Bioscience in 2016 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 19 increasing their positions, 34 reducing their positions, and 14 closing their positions.
7% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 14
0% more funds holding
Funds holding: 81 → 81 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $72.1M → $65.1M (-$6.99M)
44% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$1.88M |
| 2 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$1.07M |
| 3 |
Millennium Management
New York
|
+$589K |
| 4 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$466K |
| 5 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$464K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$2.52M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$991K |
| 3 |
State Street
Boston,
Massachusetts
|
-$961K |
| 4 |
KAM
Knightsbridge Asset Management
Newport Beach,
California
|
-$831K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$830K |
HBIO Hedge Fund Activity: Q2 2016 in Review
81 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Harvard Bioscience (HBIO) for Q2 2016, worth a combined $65.1M — down 9.7% from $72.1M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new HBIO positions and 14 closed out — a net gain of 1 holder — while 19 added to existing stakes and 34 trimmed.
The largest buyer was First Light Asset Management, adding an estimated $1.88M. The largest seller was BlackRock Fund Advisors, cutting an estimated $2.52M.
- 81 institutional investors held Harvard Bioscience (HBIO) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $65.1M of Harvard Bioscience stock for Q2 2016, down 9.7% quarter-over-quarter.
- 15 funds opened new Harvard Bioscience positions in Q2 2016 and 14 closed out, a net change of +1 holder.
- The largest Harvard Bioscience buyer in Q2 2016 was First Light Asset Management, an estimated $1.88M added.
- The largest Harvard Bioscience seller in Q2 2016 was BlackRock Fund Advisors, an estimated $2.52M sold.
Based on aggregated 13F filings for Q2 2016.